AbCellera Biologics Stock (NASDAQ: ABCL) stock price, news, charts, stock research, profile.
You can purchase shares of AbCellera Biologics (NASDAQ:ABCL) through any online brokerage.
Other companies in AbCellera Biologics’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Sotera Health (NASDAQ:SHC) and Quanterix (NASDAQ:QTRX).
AbCellera Biologics has a consensus price target of $21.11.
The stock price for AbCellera Biologics (NASDAQ: ABCL) is $2.75 last updated November 21, 2024 at 6:19 PM EST.
There are no upcoming dividends for AbCellera Biologics.
AbCellera Biologics’s Q4 earnings are confirmed for Tuesday, February 18, 2025.
There is no upcoming split for AbCellera Biologics.
AbCellera Biologics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.